from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0181c/-

LFCtreatmentdescriptionclass of inhibitor

-1.435

Amikacinug/mL Amikacintranslation

-1.678

Cap5-10ug/mL Capreomycintranslation

-1.437

Rox10-50 ug/mL Roxithromycintranslation

-0.930

SM2-5 ug/mL Streptomycintranslation

-0.280

Tet5-10 ug/mL Tetracyclinetranslation

-0.369

Rif0.2-5ug/mL Rifampicintranscription

-0.371

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.690

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.067

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.089

CPZ10-50 ug/mL Chlorpromazinerespiration

1.535

Clofazimine10-13 ug/mL Clofaziminerespiration

0.122

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.942

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.886

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.241

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.159

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.268

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.490

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.163

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.036

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.031

KCN5-20 ug/mL Potassium cyaniderespiration

0.239

NaN30.2-2 mM Sodium aziderespiration

-0.464

Nigericin50 uM Nigericinrespiration

0.234

TRC10-150 ug/mL Triclosanrespiration

0.714

TRZ10-25 ug/mL Thioridazinerespiration

0.014

Valinomycin0.5-10 uM Valinomycinrespiration

-1.431

ZnSO42 mM ZnSO4respiration

0.676

menadione6-10 ug/mL Menadionerespiration

0.252

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.428

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.094

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.456

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.185

NRP_1Non-replicating persistence stage 1dosRassociated

-1.111

Amp0.2mg/mL AmpicillincellWall

-0.097

Cephalexin20-100 ug/mL CephalexincellWall

-0.369

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.446

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.508

EMB10-20 ug/mL EthambutolcellWall

-1.220

Eta12-40 ug/mL EthionamidecellWall

-0.725

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.511

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.648

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.310

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.203

BZA0.12 mg/mL BenzamidearomaticAmides

-0.270

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.294

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.010

H2O24 mM hydrogen peroxideDNAdamaging

1.698

Levo10 ug/mL LevofloxacinDNAdamaging

0.214

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.214

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.913

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.205

UVUV-irradiationDNAdamaging

0.177

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.727

Antimycin12.5-50 ug/mL Antimycin A?

-0.246

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.590

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.458

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.504

PA8240.2-2 ug/mL PA-824?

0.690

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.024

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.003

Verapamil50 uM Verapamil?

-0.554

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.243

methoxatin10-20 ug/mL Methoxatin?